Cargando…
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal Insulin Combined Oral Therapy (Metformin and Glimepiride) in the Current Era
BACKGROUND AND AIM: Basal insulin combined oral therapy consisting of insulin and oral anti-diabetic drugs (OADs) is recommended for type 2 diabetes uncontrolled on OADs. There is a lack of clear evidence and recommendations on the combined use of basal insulin analogues to more than one OADs (glime...
Autores principales: | Shrivastava, Abhishek, Kesavadev, Jothydev, Mohan, Viswanathan, Saboo, Banshi, Shrestha, Dina, Maheshwari, Anuj, Makkar, Brij Mohan, Modi, Kirtikumar D., Das, Ashok Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617787/ https://www.ncbi.nlm.nih.gov/pubmed/36624650 http://dx.doi.org/10.2174/1573399819666230109104300 |
Ejemplares similares
-
Evolving Scope of Clinical Empathy in the Current Era of Medical Practice
por: B, Jayakrishnan, et al.
Publicado: (2023) -
Sitagliptin 100 mg vs glimepiride 1–3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM)
por: Kesavadev, Jothydev, et al.
Publicado: (2017) -
Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines
por: Mohan, Viswanathan, et al.
Publicado: (2022) -
Telemedicine for diabetes care: An Indian perspective - feasibility and efficacy
por: Kesavadev, Jothydev, et al.
Publicado: (2015) -
Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel
por: Chawla, Manoj, et al.
Publicado: (2020)